Global Biologics Monoclonal Antibodies Drug Supply, Demand and Key Producers, 2023-2029
The global Biologics Monoclonal Antibodies Drug market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
Monoclonal antibodies are immune system proteins that are created in the lab. Antibodies are produced naturally by your body and help the immune system recognize germs that cause disease, such as bacteria and viruses, and mark them for destruction. Like your body’s own antibodies, monoclonal antibodies recognize specific targets.
This report studies the global Biologics Monoclonal Antibodies Drug demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Biologics Monoclonal Antibodies Drug, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Biologics Monoclonal Antibodies Drug that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Biologics Monoclonal Antibodies Drug total market, 2018-2029, (USD Million)
Global Biologics Monoclonal Antibodies Drug total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Biologics Monoclonal Antibodies Drug total market, key domestic companies and share, (USD Million)
Global Biologics Monoclonal Antibodies Drug revenue by player and market share 2018-2023, (USD Million)
Global Biologics Monoclonal Antibodies Drug total market by Type, CAGR, 2018-2029, (USD Million)
Global Biologics Monoclonal Antibodies Drug total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Biologics Monoclonal Antibodies Drug market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Amgen, AbbVie, Sanofi, Johnson & Johnson, Pfizer, Eli Lilly, Novartis and Merck, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Biologics Monoclonal Antibodies Drug market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Biologics Monoclonal Antibodies Drug Market, By Region:
1. How big is the global Biologics Monoclonal Antibodies Drug market?
2. What is the demand of the global Biologics Monoclonal Antibodies Drug market?
3. What is the year over year growth of the global Biologics Monoclonal Antibodies Drug market?
4. What is the total value of the global Biologics Monoclonal Antibodies Drug market?
5. Who are the major players in the global Biologics Monoclonal Antibodies Drug market?
6. What are the growth factors driving the market demand?
Monoclonal antibodies are immune system proteins that are created in the lab. Antibodies are produced naturally by your body and help the immune system recognize germs that cause disease, such as bacteria and viruses, and mark them for destruction. Like your body’s own antibodies, monoclonal antibodies recognize specific targets.
This report studies the global Biologics Monoclonal Antibodies Drug demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Biologics Monoclonal Antibodies Drug, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Biologics Monoclonal Antibodies Drug that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Biologics Monoclonal Antibodies Drug total market, 2018-2029, (USD Million)
Global Biologics Monoclonal Antibodies Drug total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Biologics Monoclonal Antibodies Drug total market, key domestic companies and share, (USD Million)
Global Biologics Monoclonal Antibodies Drug revenue by player and market share 2018-2023, (USD Million)
Global Biologics Monoclonal Antibodies Drug total market by Type, CAGR, 2018-2029, (USD Million)
Global Biologics Monoclonal Antibodies Drug total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Biologics Monoclonal Antibodies Drug market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Amgen, AbbVie, Sanofi, Johnson & Johnson, Pfizer, Eli Lilly, Novartis and Merck, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Biologics Monoclonal Antibodies Drug market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Biologics Monoclonal Antibodies Drug Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Infliximab
- Rituximab
- Trastuzumab
- Adalimumab
- Other
- Cancer
- Autoimmune Disease
- Other
- Roche
- Amgen
- AbbVie
- Sanofi
- Johnson & Johnson
- Pfizer
- Eli Lilly
- Novartis
- Merck
- Biogen
- Sobi
- Innovent Biologics
1. How big is the global Biologics Monoclonal Antibodies Drug market?
2. What is the demand of the global Biologics Monoclonal Antibodies Drug market?
3. What is the year over year growth of the global Biologics Monoclonal Antibodies Drug market?
4. What is the total value of the global Biologics Monoclonal Antibodies Drug market?
5. Who are the major players in the global Biologics Monoclonal Antibodies Drug market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Biologics Monoclonal Antibodies Drug Introduction
1.2 World Biologics Monoclonal Antibodies Drug Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Biologics Monoclonal Antibodies Drug Total Market by Region (by Headquarter Location)
1.3.1 World Biologics Monoclonal Antibodies Drug Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Biologics Monoclonal Antibodies Drug Market Size (2018-2029)
1.3.3 China Biologics Monoclonal Antibodies Drug Market Size (2018-2029)
1.3.4 Europe Biologics Monoclonal Antibodies Drug Market Size (2018-2029)
1.3.5 Japan Biologics Monoclonal Antibodies Drug Market Size (2018-2029)
1.3.6 South Korea Biologics Monoclonal Antibodies Drug Market Size (2018-2029)
1.3.7 ASEAN Biologics Monoclonal Antibodies Drug Market Size (2018-2029)
1.3.8 India Biologics Monoclonal Antibodies Drug Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Biologics Monoclonal Antibodies Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Biologics Monoclonal Antibodies Drug Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Biologics Monoclonal Antibodies Drug Consumption Value (2018-2029)
2.2 World Biologics Monoclonal Antibodies Drug Consumption Value by Region
2.2.1 World Biologics Monoclonal Antibodies Drug Consumption Value by Region (2018-2023)
2.2.2 World Biologics Monoclonal Antibodies Drug Consumption Value Forecast by Region (2024-2029)
2.3 United States Biologics Monoclonal Antibodies Drug Consumption Value (2018-2029)
2.4 China Biologics Monoclonal Antibodies Drug Consumption Value (2018-2029)
2.5 Europe Biologics Monoclonal Antibodies Drug Consumption Value (2018-2029)
2.6 Japan Biologics Monoclonal Antibodies Drug Consumption Value (2018-2029)
2.7 South Korea Biologics Monoclonal Antibodies Drug Consumption Value (2018-2029)
2.8 ASEAN Biologics Monoclonal Antibodies Drug Consumption Value (2018-2029)
2.9 India Biologics Monoclonal Antibodies Drug Consumption Value (2018-2029)
3 WORLD BIOLOGICS MONOCLONAL ANTIBODIES DRUG COMPANIES COMPETITIVE ANALYSIS
3.1 World Biologics Monoclonal Antibodies Drug Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Biologics Monoclonal Antibodies Drug Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Biologics Monoclonal Antibodies Drug in 2022
3.2.3 Global Concentration Ratios (CR8) for Biologics Monoclonal Antibodies Drug in 2022
3.3 Biologics Monoclonal Antibodies Drug Company Evaluation Quadrant
3.4 Biologics Monoclonal Antibodies Drug Market: Overall Company Footprint Analysis
3.4.1 Biologics Monoclonal Antibodies Drug Market: Region Footprint
3.4.2 Biologics Monoclonal Antibodies Drug Market: Company Product Type Footprint
3.4.3 Biologics Monoclonal Antibodies Drug Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Biologics Monoclonal Antibodies Drug Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Biologics Monoclonal Antibodies Drug Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Biologics Monoclonal Antibodies Drug Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Biologics Monoclonal Antibodies Drug Consumption Value Comparison
4.2.1 United States VS China: Biologics Monoclonal Antibodies Drug Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Biologics Monoclonal Antibodies Drug Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Biologics Monoclonal Antibodies Drug Companies and Market Share, 2018-2023
4.3.1 United States Based Biologics Monoclonal Antibodies Drug Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Biologics Monoclonal Antibodies Drug Revenue, (2018-2023)
4.4 China Based Companies Biologics Monoclonal Antibodies Drug Revenue and Market Share, 2018-2023
4.4.1 China Based Biologics Monoclonal Antibodies Drug Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Biologics Monoclonal Antibodies Drug Revenue, (2018-2023)
4.5 Rest of World Based Biologics Monoclonal Antibodies Drug Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Biologics Monoclonal Antibodies Drug Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Biologics Monoclonal Antibodies Drug Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Biologics Monoclonal Antibodies Drug Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Infliximab
5.2.2 Rituximab
5.2.3 Trastuzumab
5.2.4 Adalimumab
5.2.5 Other
5.3 Market Segment by Type
5.3.1 World Biologics Monoclonal Antibodies Drug Market Size by Type (2018-2023)
5.3.2 World Biologics Monoclonal Antibodies Drug Market Size by Type (2024-2029)
5.3.3 World Biologics Monoclonal Antibodies Drug Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Biologics Monoclonal Antibodies Drug Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Cancer
6.2.2 Autoimmune Disease
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Biologics Monoclonal Antibodies Drug Market Size by Application (2018-2023)
6.3.2 World Biologics Monoclonal Antibodies Drug Market Size by Application (2024-2029)
6.3.3 World Biologics Monoclonal Antibodies Drug Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Roche
7.1.1 Roche Details
7.1.2 Roche Major Business
7.1.3 Roche Biologics Monoclonal Antibodies Drug Product and Services
7.1.4 Roche Biologics Monoclonal Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Roche Recent Developments/Updates
7.1.6 Roche Competitive Strengths & Weaknesses
7.2 Amgen
7.2.1 Amgen Details
7.2.2 Amgen Major Business
7.2.3 Amgen Biologics Monoclonal Antibodies Drug Product and Services
7.2.4 Amgen Biologics Monoclonal Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Amgen Recent Developments/Updates
7.2.6 Amgen Competitive Strengths & Weaknesses
7.3 AbbVie
7.3.1 AbbVie Details
7.3.2 AbbVie Major Business
7.3.3 AbbVie Biologics Monoclonal Antibodies Drug Product and Services
7.3.4 AbbVie Biologics Monoclonal Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 AbbVie Recent Developments/Updates
7.3.6 AbbVie Competitive Strengths & Weaknesses
7.4 Sanofi
7.4.1 Sanofi Details
7.4.2 Sanofi Major Business
7.4.3 Sanofi Biologics Monoclonal Antibodies Drug Product and Services
7.4.4 Sanofi Biologics Monoclonal Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Sanofi Recent Developments/Updates
7.4.6 Sanofi Competitive Strengths & Weaknesses
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Details
7.5.2 Johnson & Johnson Major Business
7.5.3 Johnson & Johnson Biologics Monoclonal Antibodies Drug Product and Services
7.5.4 Johnson & Johnson Biologics Monoclonal Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Johnson & Johnson Recent Developments/Updates
7.5.6 Johnson & Johnson Competitive Strengths & Weaknesses
7.6 Pfizer
7.6.1 Pfizer Details
7.6.2 Pfizer Major Business
7.6.3 Pfizer Biologics Monoclonal Antibodies Drug Product and Services
7.6.4 Pfizer Biologics Monoclonal Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Pfizer Recent Developments/Updates
7.6.6 Pfizer Competitive Strengths & Weaknesses
7.7 Eli Lilly
7.7.1 Eli Lilly Details
7.7.2 Eli Lilly Major Business
7.7.3 Eli Lilly Biologics Monoclonal Antibodies Drug Product and Services
7.7.4 Eli Lilly Biologics Monoclonal Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Eli Lilly Recent Developments/Updates
7.7.6 Eli Lilly Competitive Strengths & Weaknesses
7.8 Novartis
7.8.1 Novartis Details
7.8.2 Novartis Major Business
7.8.3 Novartis Biologics Monoclonal Antibodies Drug Product and Services
7.8.4 Novartis Biologics Monoclonal Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Novartis Recent Developments/Updates
7.8.6 Novartis Competitive Strengths & Weaknesses
7.9 Merck
7.9.1 Merck Details
7.9.2 Merck Major Business
7.9.3 Merck Biologics Monoclonal Antibodies Drug Product and Services
7.9.4 Merck Biologics Monoclonal Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Merck Recent Developments/Updates
7.9.6 Merck Competitive Strengths & Weaknesses
7.10 Biogen
7.10.1 Biogen Details
7.10.2 Biogen Major Business
7.10.3 Biogen Biologics Monoclonal Antibodies Drug Product and Services
7.10.4 Biogen Biologics Monoclonal Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Biogen Recent Developments/Updates
7.10.6 Biogen Competitive Strengths & Weaknesses
7.11 Sobi
7.11.1 Sobi Details
7.11.2 Sobi Major Business
7.11.3 Sobi Biologics Monoclonal Antibodies Drug Product and Services
7.11.4 Sobi Biologics Monoclonal Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Sobi Recent Developments/Updates
7.11.6 Sobi Competitive Strengths & Weaknesses
7.12 Innovent Biologics
7.12.1 Innovent Biologics Details
7.12.2 Innovent Biologics Major Business
7.12.3 Innovent Biologics Biologics Monoclonal Antibodies Drug Product and Services
7.12.4 Innovent Biologics Biologics Monoclonal Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Innovent Biologics Recent Developments/Updates
7.12.6 Innovent Biologics Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Biologics Monoclonal Antibodies Drug Industry Chain
8.2 Biologics Monoclonal Antibodies Drug Upstream Analysis
8.3 Biologics Monoclonal Antibodies Drug Midstream Analysis
8.4 Biologics Monoclonal Antibodies Drug Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Biologics Monoclonal Antibodies Drug Introduction
1.2 World Biologics Monoclonal Antibodies Drug Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Biologics Monoclonal Antibodies Drug Total Market by Region (by Headquarter Location)
1.3.1 World Biologics Monoclonal Antibodies Drug Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Biologics Monoclonal Antibodies Drug Market Size (2018-2029)
1.3.3 China Biologics Monoclonal Antibodies Drug Market Size (2018-2029)
1.3.4 Europe Biologics Monoclonal Antibodies Drug Market Size (2018-2029)
1.3.5 Japan Biologics Monoclonal Antibodies Drug Market Size (2018-2029)
1.3.6 South Korea Biologics Monoclonal Antibodies Drug Market Size (2018-2029)
1.3.7 ASEAN Biologics Monoclonal Antibodies Drug Market Size (2018-2029)
1.3.8 India Biologics Monoclonal Antibodies Drug Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Biologics Monoclonal Antibodies Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Biologics Monoclonal Antibodies Drug Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Biologics Monoclonal Antibodies Drug Consumption Value (2018-2029)
2.2 World Biologics Monoclonal Antibodies Drug Consumption Value by Region
2.2.1 World Biologics Monoclonal Antibodies Drug Consumption Value by Region (2018-2023)
2.2.2 World Biologics Monoclonal Antibodies Drug Consumption Value Forecast by Region (2024-2029)
2.3 United States Biologics Monoclonal Antibodies Drug Consumption Value (2018-2029)
2.4 China Biologics Monoclonal Antibodies Drug Consumption Value (2018-2029)
2.5 Europe Biologics Monoclonal Antibodies Drug Consumption Value (2018-2029)
2.6 Japan Biologics Monoclonal Antibodies Drug Consumption Value (2018-2029)
2.7 South Korea Biologics Monoclonal Antibodies Drug Consumption Value (2018-2029)
2.8 ASEAN Biologics Monoclonal Antibodies Drug Consumption Value (2018-2029)
2.9 India Biologics Monoclonal Antibodies Drug Consumption Value (2018-2029)
3 WORLD BIOLOGICS MONOCLONAL ANTIBODIES DRUG COMPANIES COMPETITIVE ANALYSIS
3.1 World Biologics Monoclonal Antibodies Drug Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Biologics Monoclonal Antibodies Drug Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Biologics Monoclonal Antibodies Drug in 2022
3.2.3 Global Concentration Ratios (CR8) for Biologics Monoclonal Antibodies Drug in 2022
3.3 Biologics Monoclonal Antibodies Drug Company Evaluation Quadrant
3.4 Biologics Monoclonal Antibodies Drug Market: Overall Company Footprint Analysis
3.4.1 Biologics Monoclonal Antibodies Drug Market: Region Footprint
3.4.2 Biologics Monoclonal Antibodies Drug Market: Company Product Type Footprint
3.4.3 Biologics Monoclonal Antibodies Drug Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Biologics Monoclonal Antibodies Drug Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Biologics Monoclonal Antibodies Drug Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Biologics Monoclonal Antibodies Drug Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Biologics Monoclonal Antibodies Drug Consumption Value Comparison
4.2.1 United States VS China: Biologics Monoclonal Antibodies Drug Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Biologics Monoclonal Antibodies Drug Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Biologics Monoclonal Antibodies Drug Companies and Market Share, 2018-2023
4.3.1 United States Based Biologics Monoclonal Antibodies Drug Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Biologics Monoclonal Antibodies Drug Revenue, (2018-2023)
4.4 China Based Companies Biologics Monoclonal Antibodies Drug Revenue and Market Share, 2018-2023
4.4.1 China Based Biologics Monoclonal Antibodies Drug Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Biologics Monoclonal Antibodies Drug Revenue, (2018-2023)
4.5 Rest of World Based Biologics Monoclonal Antibodies Drug Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Biologics Monoclonal Antibodies Drug Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Biologics Monoclonal Antibodies Drug Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Biologics Monoclonal Antibodies Drug Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Infliximab
5.2.2 Rituximab
5.2.3 Trastuzumab
5.2.4 Adalimumab
5.2.5 Other
5.3 Market Segment by Type
5.3.1 World Biologics Monoclonal Antibodies Drug Market Size by Type (2018-2023)
5.3.2 World Biologics Monoclonal Antibodies Drug Market Size by Type (2024-2029)
5.3.3 World Biologics Monoclonal Antibodies Drug Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Biologics Monoclonal Antibodies Drug Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Cancer
6.2.2 Autoimmune Disease
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Biologics Monoclonal Antibodies Drug Market Size by Application (2018-2023)
6.3.2 World Biologics Monoclonal Antibodies Drug Market Size by Application (2024-2029)
6.3.3 World Biologics Monoclonal Antibodies Drug Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Roche
7.1.1 Roche Details
7.1.2 Roche Major Business
7.1.3 Roche Biologics Monoclonal Antibodies Drug Product and Services
7.1.4 Roche Biologics Monoclonal Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Roche Recent Developments/Updates
7.1.6 Roche Competitive Strengths & Weaknesses
7.2 Amgen
7.2.1 Amgen Details
7.2.2 Amgen Major Business
7.2.3 Amgen Biologics Monoclonal Antibodies Drug Product and Services
7.2.4 Amgen Biologics Monoclonal Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Amgen Recent Developments/Updates
7.2.6 Amgen Competitive Strengths & Weaknesses
7.3 AbbVie
7.3.1 AbbVie Details
7.3.2 AbbVie Major Business
7.3.3 AbbVie Biologics Monoclonal Antibodies Drug Product and Services
7.3.4 AbbVie Biologics Monoclonal Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 AbbVie Recent Developments/Updates
7.3.6 AbbVie Competitive Strengths & Weaknesses
7.4 Sanofi
7.4.1 Sanofi Details
7.4.2 Sanofi Major Business
7.4.3 Sanofi Biologics Monoclonal Antibodies Drug Product and Services
7.4.4 Sanofi Biologics Monoclonal Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Sanofi Recent Developments/Updates
7.4.6 Sanofi Competitive Strengths & Weaknesses
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Details
7.5.2 Johnson & Johnson Major Business
7.5.3 Johnson & Johnson Biologics Monoclonal Antibodies Drug Product and Services
7.5.4 Johnson & Johnson Biologics Monoclonal Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Johnson & Johnson Recent Developments/Updates
7.5.6 Johnson & Johnson Competitive Strengths & Weaknesses
7.6 Pfizer
7.6.1 Pfizer Details
7.6.2 Pfizer Major Business
7.6.3 Pfizer Biologics Monoclonal Antibodies Drug Product and Services
7.6.4 Pfizer Biologics Monoclonal Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Pfizer Recent Developments/Updates
7.6.6 Pfizer Competitive Strengths & Weaknesses
7.7 Eli Lilly
7.7.1 Eli Lilly Details
7.7.2 Eli Lilly Major Business
7.7.3 Eli Lilly Biologics Monoclonal Antibodies Drug Product and Services
7.7.4 Eli Lilly Biologics Monoclonal Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Eli Lilly Recent Developments/Updates
7.7.6 Eli Lilly Competitive Strengths & Weaknesses
7.8 Novartis
7.8.1 Novartis Details
7.8.2 Novartis Major Business
7.8.3 Novartis Biologics Monoclonal Antibodies Drug Product and Services
7.8.4 Novartis Biologics Monoclonal Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Novartis Recent Developments/Updates
7.8.6 Novartis Competitive Strengths & Weaknesses
7.9 Merck
7.9.1 Merck Details
7.9.2 Merck Major Business
7.9.3 Merck Biologics Monoclonal Antibodies Drug Product and Services
7.9.4 Merck Biologics Monoclonal Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Merck Recent Developments/Updates
7.9.6 Merck Competitive Strengths & Weaknesses
7.10 Biogen
7.10.1 Biogen Details
7.10.2 Biogen Major Business
7.10.3 Biogen Biologics Monoclonal Antibodies Drug Product and Services
7.10.4 Biogen Biologics Monoclonal Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Biogen Recent Developments/Updates
7.10.6 Biogen Competitive Strengths & Weaknesses
7.11 Sobi
7.11.1 Sobi Details
7.11.2 Sobi Major Business
7.11.3 Sobi Biologics Monoclonal Antibodies Drug Product and Services
7.11.4 Sobi Biologics Monoclonal Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Sobi Recent Developments/Updates
7.11.6 Sobi Competitive Strengths & Weaknesses
7.12 Innovent Biologics
7.12.1 Innovent Biologics Details
7.12.2 Innovent Biologics Major Business
7.12.3 Innovent Biologics Biologics Monoclonal Antibodies Drug Product and Services
7.12.4 Innovent Biologics Biologics Monoclonal Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Innovent Biologics Recent Developments/Updates
7.12.6 Innovent Biologics Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Biologics Monoclonal Antibodies Drug Industry Chain
8.2 Biologics Monoclonal Antibodies Drug Upstream Analysis
8.3 Biologics Monoclonal Antibodies Drug Midstream Analysis
8.4 Biologics Monoclonal Antibodies Drug Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Biologics Monoclonal Antibodies Drug Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Biologics Monoclonal Antibodies Drug Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Biologics Monoclonal Antibodies Drug Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Biologics Monoclonal Antibodies Drug Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Biologics Monoclonal Antibodies Drug Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Biologics Monoclonal Antibodies Drug Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Biologics Monoclonal Antibodies Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Biologics Monoclonal Antibodies Drug Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Biologics Monoclonal Antibodies Drug Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Biologics Monoclonal Antibodies Drug Players in 2022
Table 12. World Biologics Monoclonal Antibodies Drug Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Biologics Monoclonal Antibodies Drug Company Evaluation Quadrant
Table 14. Head Office of Key Biologics Monoclonal Antibodies Drug Player
Table 15. Biologics Monoclonal Antibodies Drug Market: Company Product Type Footprint
Table 16. Biologics Monoclonal Antibodies Drug Market: Company Product Application Footprint
Table 17. Biologics Monoclonal Antibodies Drug Mergers & Acquisitions Activity
Table 18. United States VS China Biologics Monoclonal Antibodies Drug Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Biologics Monoclonal Antibodies Drug Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Biologics Monoclonal Antibodies Drug Companies, Headquarters (States, Country)
Table 21. United States Based Companies Biologics Monoclonal Antibodies Drug Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Biologics Monoclonal Antibodies Drug Revenue Market Share (2018-2023)
Table 23. China Based Biologics Monoclonal Antibodies Drug Companies, Headquarters (Province, Country)
Table 24. China Based Companies Biologics Monoclonal Antibodies Drug Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Biologics Monoclonal Antibodies Drug Revenue Market Share (2018-2023)
Table 26. Rest of World Based Biologics Monoclonal Antibodies Drug Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Biologics Monoclonal Antibodies Drug Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Biologics Monoclonal Antibodies Drug Revenue Market Share (2018-2023)
Table 29. World Biologics Monoclonal Antibodies Drug Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Biologics Monoclonal Antibodies Drug Market Size by Type (2018-2023) & (USD Million)
Table 31. World Biologics Monoclonal Antibodies Drug Market Size by Type (2024-2029) & (USD Million)
Table 32. World Biologics Monoclonal Antibodies Drug Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Biologics Monoclonal Antibodies Drug Market Size by Application (2018-2023) & (USD Million)
Table 34. World Biologics Monoclonal Antibodies Drug Market Size by Application (2024-2029) & (USD Million)
Table 35. Roche Basic Information, Area Served and Competitors
Table 36. Roche Major Business
Table 37. Roche Biologics Monoclonal Antibodies Drug Product and Services
Table 38. Roche Biologics Monoclonal Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Roche Recent Developments/Updates
Table 40. Roche Competitive Strengths & Weaknesses
Table 41. Amgen Basic Information, Area Served and Competitors
Table 42. Amgen Major Business
Table 43. Amgen Biologics Monoclonal Antibodies Drug Product and Services
Table 44. Amgen Biologics Monoclonal Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Amgen Recent Developments/Updates
Table 46. Amgen Competitive Strengths & Weaknesses
Table 47. AbbVie Basic Information, Area Served and Competitors
Table 48. AbbVie Major Business
Table 49. AbbVie Biologics Monoclonal Antibodies Drug Product and Services
Table 50. AbbVie Biologics Monoclonal Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. AbbVie Recent Developments/Updates
Table 52. AbbVie Competitive Strengths & Weaknesses
Table 53. Sanofi Basic Information, Area Served and Competitors
Table 54. Sanofi Major Business
Table 55. Sanofi Biologics Monoclonal Antibodies Drug Product and Services
Table 56. Sanofi Biologics Monoclonal Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Sanofi Recent Developments/Updates
Table 58. Sanofi Competitive Strengths & Weaknesses
Table 59. Johnson & Johnson Basic Information, Area Served and Competitors
Table 60. Johnson & Johnson Major Business
Table 61. Johnson & Johnson Biologics Monoclonal Antibodies Drug Product and Services
Table 62. Johnson & Johnson Biologics Monoclonal Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Johnson & Johnson Recent Developments/Updates
Table 64. Johnson & Johnson Competitive Strengths & Weaknesses
Table 65. Pfizer Basic Information, Area Served and Competitors
Table 66. Pfizer Major Business
Table 67. Pfizer Biologics Monoclonal Antibodies Drug Product and Services
Table 68. Pfizer Biologics Monoclonal Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Pfizer Recent Developments/Updates
Table 70. Pfizer Competitive Strengths & Weaknesses
Table 71. Eli Lilly Basic Information, Area Served and Competitors
Table 72. Eli Lilly Major Business
Table 73. Eli Lilly Biologics Monoclonal Antibodies Drug Product and Services
Table 74. Eli Lilly Biologics Monoclonal Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Eli Lilly Recent Developments/Updates
Table 76. Eli Lilly Competitive Strengths & Weaknesses
Table 77. Novartis Basic Information, Area Served and Competitors
Table 78. Novartis Major Business
Table 79. Novartis Biologics Monoclonal Antibodies Drug Product and Services
Table 80. Novartis Biologics Monoclonal Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Novartis Recent Developments/Updates
Table 82. Novartis Competitive Strengths & Weaknesses
Table 83. Merck Basic Information, Area Served and Competitors
Table 84. Merck Major Business
Table 85. Merck Biologics Monoclonal Antibodies Drug Product and Services
Table 86. Merck Biologics Monoclonal Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Merck Recent Developments/Updates
Table 88. Merck Competitive Strengths & Weaknesses
Table 89. Biogen Basic Information, Area Served and Competitors
Table 90. Biogen Major Business
Table 91. Biogen Biologics Monoclonal Antibodies Drug Product and Services
Table 92. Biogen Biologics Monoclonal Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Biogen Recent Developments/Updates
Table 94. Biogen Competitive Strengths & Weaknesses
Table 95. Sobi Basic Information, Area Served and Competitors
Table 96. Sobi Major Business
Table 97. Sobi Biologics Monoclonal Antibodies Drug Product and Services
Table 98. Sobi Biologics Monoclonal Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Sobi Recent Developments/Updates
Table 100. Innovent Biologics Basic Information, Area Served and Competitors
Table 101. Innovent Biologics Major Business
Table 102. Innovent Biologics Biologics Monoclonal Antibodies Drug Product and Services
Table 103. Innovent Biologics Biologics Monoclonal Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 104. Global Key Players of Biologics Monoclonal Antibodies Drug Upstream (Raw Materials)
Table 105. Biologics Monoclonal Antibodies Drug Typical Customers
Table 1. World Biologics Monoclonal Antibodies Drug Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Biologics Monoclonal Antibodies Drug Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Biologics Monoclonal Antibodies Drug Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Biologics Monoclonal Antibodies Drug Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Biologics Monoclonal Antibodies Drug Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Biologics Monoclonal Antibodies Drug Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Biologics Monoclonal Antibodies Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Biologics Monoclonal Antibodies Drug Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Biologics Monoclonal Antibodies Drug Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Biologics Monoclonal Antibodies Drug Players in 2022
Table 12. World Biologics Monoclonal Antibodies Drug Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Biologics Monoclonal Antibodies Drug Company Evaluation Quadrant
Table 14. Head Office of Key Biologics Monoclonal Antibodies Drug Player
Table 15. Biologics Monoclonal Antibodies Drug Market: Company Product Type Footprint
Table 16. Biologics Monoclonal Antibodies Drug Market: Company Product Application Footprint
Table 17. Biologics Monoclonal Antibodies Drug Mergers & Acquisitions Activity
Table 18. United States VS China Biologics Monoclonal Antibodies Drug Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Biologics Monoclonal Antibodies Drug Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Biologics Monoclonal Antibodies Drug Companies, Headquarters (States, Country)
Table 21. United States Based Companies Biologics Monoclonal Antibodies Drug Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Biologics Monoclonal Antibodies Drug Revenue Market Share (2018-2023)
Table 23. China Based Biologics Monoclonal Antibodies Drug Companies, Headquarters (Province, Country)
Table 24. China Based Companies Biologics Monoclonal Antibodies Drug Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Biologics Monoclonal Antibodies Drug Revenue Market Share (2018-2023)
Table 26. Rest of World Based Biologics Monoclonal Antibodies Drug Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Biologics Monoclonal Antibodies Drug Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Biologics Monoclonal Antibodies Drug Revenue Market Share (2018-2023)
Table 29. World Biologics Monoclonal Antibodies Drug Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Biologics Monoclonal Antibodies Drug Market Size by Type (2018-2023) & (USD Million)
Table 31. World Biologics Monoclonal Antibodies Drug Market Size by Type (2024-2029) & (USD Million)
Table 32. World Biologics Monoclonal Antibodies Drug Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Biologics Monoclonal Antibodies Drug Market Size by Application (2018-2023) & (USD Million)
Table 34. World Biologics Monoclonal Antibodies Drug Market Size by Application (2024-2029) & (USD Million)
Table 35. Roche Basic Information, Area Served and Competitors
Table 36. Roche Major Business
Table 37. Roche Biologics Monoclonal Antibodies Drug Product and Services
Table 38. Roche Biologics Monoclonal Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Roche Recent Developments/Updates
Table 40. Roche Competitive Strengths & Weaknesses
Table 41. Amgen Basic Information, Area Served and Competitors
Table 42. Amgen Major Business
Table 43. Amgen Biologics Monoclonal Antibodies Drug Product and Services
Table 44. Amgen Biologics Monoclonal Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Amgen Recent Developments/Updates
Table 46. Amgen Competitive Strengths & Weaknesses
Table 47. AbbVie Basic Information, Area Served and Competitors
Table 48. AbbVie Major Business
Table 49. AbbVie Biologics Monoclonal Antibodies Drug Product and Services
Table 50. AbbVie Biologics Monoclonal Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. AbbVie Recent Developments/Updates
Table 52. AbbVie Competitive Strengths & Weaknesses
Table 53. Sanofi Basic Information, Area Served and Competitors
Table 54. Sanofi Major Business
Table 55. Sanofi Biologics Monoclonal Antibodies Drug Product and Services
Table 56. Sanofi Biologics Monoclonal Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Sanofi Recent Developments/Updates
Table 58. Sanofi Competitive Strengths & Weaknesses
Table 59. Johnson & Johnson Basic Information, Area Served and Competitors
Table 60. Johnson & Johnson Major Business
Table 61. Johnson & Johnson Biologics Monoclonal Antibodies Drug Product and Services
Table 62. Johnson & Johnson Biologics Monoclonal Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Johnson & Johnson Recent Developments/Updates
Table 64. Johnson & Johnson Competitive Strengths & Weaknesses
Table 65. Pfizer Basic Information, Area Served and Competitors
Table 66. Pfizer Major Business
Table 67. Pfizer Biologics Monoclonal Antibodies Drug Product and Services
Table 68. Pfizer Biologics Monoclonal Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Pfizer Recent Developments/Updates
Table 70. Pfizer Competitive Strengths & Weaknesses
Table 71. Eli Lilly Basic Information, Area Served and Competitors
Table 72. Eli Lilly Major Business
Table 73. Eli Lilly Biologics Monoclonal Antibodies Drug Product and Services
Table 74. Eli Lilly Biologics Monoclonal Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Eli Lilly Recent Developments/Updates
Table 76. Eli Lilly Competitive Strengths & Weaknesses
Table 77. Novartis Basic Information, Area Served and Competitors
Table 78. Novartis Major Business
Table 79. Novartis Biologics Monoclonal Antibodies Drug Product and Services
Table 80. Novartis Biologics Monoclonal Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Novartis Recent Developments/Updates
Table 82. Novartis Competitive Strengths & Weaknesses
Table 83. Merck Basic Information, Area Served and Competitors
Table 84. Merck Major Business
Table 85. Merck Biologics Monoclonal Antibodies Drug Product and Services
Table 86. Merck Biologics Monoclonal Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Merck Recent Developments/Updates
Table 88. Merck Competitive Strengths & Weaknesses
Table 89. Biogen Basic Information, Area Served and Competitors
Table 90. Biogen Major Business
Table 91. Biogen Biologics Monoclonal Antibodies Drug Product and Services
Table 92. Biogen Biologics Monoclonal Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Biogen Recent Developments/Updates
Table 94. Biogen Competitive Strengths & Weaknesses
Table 95. Sobi Basic Information, Area Served and Competitors
Table 96. Sobi Major Business
Table 97. Sobi Biologics Monoclonal Antibodies Drug Product and Services
Table 98. Sobi Biologics Monoclonal Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Sobi Recent Developments/Updates
Table 100. Innovent Biologics Basic Information, Area Served and Competitors
Table 101. Innovent Biologics Major Business
Table 102. Innovent Biologics Biologics Monoclonal Antibodies Drug Product and Services
Table 103. Innovent Biologics Biologics Monoclonal Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 104. Global Key Players of Biologics Monoclonal Antibodies Drug Upstream (Raw Materials)
Table 105. Biologics Monoclonal Antibodies Drug Typical Customers
LIST OF FIGURES
Figure 1. Biologics Monoclonal Antibodies Drug Picture
Figure 2. World Biologics Monoclonal Antibodies Drug Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Biologics Monoclonal Antibodies Drug Total Market Size (2018-2029) & (USD Million)
Figure 4. World Biologics Monoclonal Antibodies Drug Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Biologics Monoclonal Antibodies Drug Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Biologics Monoclonal Antibodies Drug Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Biologics Monoclonal Antibodies Drug Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Biologics Monoclonal Antibodies Drug Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Biologics Monoclonal Antibodies Drug Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Biologics Monoclonal Antibodies Drug Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Biologics Monoclonal Antibodies Drug Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Biologics Monoclonal Antibodies Drug Revenue (2018-2029) & (USD Million)
Figure 13. Biologics Monoclonal Antibodies Drug Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Biologics Monoclonal Antibodies Drug Consumption Value (2018-2029) & (USD Million)
Figure 16. World Biologics Monoclonal Antibodies Drug Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Biologics Monoclonal Antibodies Drug Consumption Value (2018-2029) & (USD Million)
Figure 18. China Biologics Monoclonal Antibodies Drug Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Biologics Monoclonal Antibodies Drug Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Biologics Monoclonal Antibodies Drug Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Biologics Monoclonal Antibodies Drug Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Biologics Monoclonal Antibodies Drug Consumption Value (2018-2029) & (USD Million)
Figure 23. India Biologics Monoclonal Antibodies Drug Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Biologics Monoclonal Antibodies Drug by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Biologics Monoclonal Antibodies Drug Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Biologics Monoclonal Antibodies Drug Markets in 2022
Figure 27. United States VS China: Biologics Monoclonal Antibodies Drug Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Biologics Monoclonal Antibodies Drug Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Biologics Monoclonal Antibodies Drug Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Biologics Monoclonal Antibodies Drug Market Size Market Share by Type in 2022
Figure 31. Infliximab
Figure 32. Rituximab
Figure 33. Trastuzumab
Figure 34. Adalimumab
Figure 35. Other
Figure 36. World Biologics Monoclonal Antibodies Drug Market Size Market Share by Type (2018-2029)
Figure 37. World Biologics Monoclonal Antibodies Drug Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 38. World Biologics Monoclonal Antibodies Drug Market Size Market Share by Application in 2022
Figure 39. Cancer
Figure 40. Autoimmune Disease
Figure 41. Other
Figure 42. Biologics Monoclonal Antibodies Drug Industrial Chain
Figure 43. Methodology
Figure 44. Research Process and Data Source
Figure 1. Biologics Monoclonal Antibodies Drug Picture
Figure 2. World Biologics Monoclonal Antibodies Drug Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Biologics Monoclonal Antibodies Drug Total Market Size (2018-2029) & (USD Million)
Figure 4. World Biologics Monoclonal Antibodies Drug Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Biologics Monoclonal Antibodies Drug Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Biologics Monoclonal Antibodies Drug Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Biologics Monoclonal Antibodies Drug Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Biologics Monoclonal Antibodies Drug Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Biologics Monoclonal Antibodies Drug Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Biologics Monoclonal Antibodies Drug Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Biologics Monoclonal Antibodies Drug Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Biologics Monoclonal Antibodies Drug Revenue (2018-2029) & (USD Million)
Figure 13. Biologics Monoclonal Antibodies Drug Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Biologics Monoclonal Antibodies Drug Consumption Value (2018-2029) & (USD Million)
Figure 16. World Biologics Monoclonal Antibodies Drug Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Biologics Monoclonal Antibodies Drug Consumption Value (2018-2029) & (USD Million)
Figure 18. China Biologics Monoclonal Antibodies Drug Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Biologics Monoclonal Antibodies Drug Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Biologics Monoclonal Antibodies Drug Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Biologics Monoclonal Antibodies Drug Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Biologics Monoclonal Antibodies Drug Consumption Value (2018-2029) & (USD Million)
Figure 23. India Biologics Monoclonal Antibodies Drug Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Biologics Monoclonal Antibodies Drug by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Biologics Monoclonal Antibodies Drug Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Biologics Monoclonal Antibodies Drug Markets in 2022
Figure 27. United States VS China: Biologics Monoclonal Antibodies Drug Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Biologics Monoclonal Antibodies Drug Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Biologics Monoclonal Antibodies Drug Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Biologics Monoclonal Antibodies Drug Market Size Market Share by Type in 2022
Figure 31. Infliximab
Figure 32. Rituximab
Figure 33. Trastuzumab
Figure 34. Adalimumab
Figure 35. Other
Figure 36. World Biologics Monoclonal Antibodies Drug Market Size Market Share by Type (2018-2029)
Figure 37. World Biologics Monoclonal Antibodies Drug Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 38. World Biologics Monoclonal Antibodies Drug Market Size Market Share by Application in 2022
Figure 39. Cancer
Figure 40. Autoimmune Disease
Figure 41. Other
Figure 42. Biologics Monoclonal Antibodies Drug Industrial Chain
Figure 43. Methodology
Figure 44. Research Process and Data Source
